✦ LIBER ✦

Antigenic Variation of Molecularly Cloned SIVmac239 during Persistent Infection in a Rhesus Macaque

✍ Scribed by S.V. Joag; M.G. Anderson; J.E. Clements; M.F. McEntee; D.P. Sharma; R.J. Adams; O. Narayan

Book ID: 112269252
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 461 KB
Volume: 195
Category: Article
ISSN: 0042-6822
DOI: 10.1006/viro.1993.1390

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dynamics and functions of CD4+CD25highre

Dynamics and functions of CD4+CD25highregulatory T lymphocytes in Chinese rhesus macaques during the early stage of infection with SIVmac239

✍ Shao-You Li, Hou-Jun Xia, Zheng-Xi Dai, Gao-Hong Zhang, Bo Fan, Ming-Hua Li, Rui 📂 Article 📅 2012 🏛 Springer Vienna 🌐 English ⚖ 420 KB

Replication kinetics and persistence of

Replication kinetics and persistence of a conditionally live attenuated SIV (SIVrtTA)in vivoconfers protection against SIVmac239 wild-type challenge in a rhesus macaque model

✍ Neil Berry, Atze Das, Mark Page, Hannah Tudor, Mark Robinson… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 104 KB

Restricted SIV Replication in Rhesus Mac

Restricted SIV Replication in Rhesus Macaque Lung Tissues During the Acute Phase of Infection

✍ Craig L. Fuller; Yang K. Choi; Beth A. Fallert; Saverio Capuano III; Premeela Ra 📂 Article 📅 2002 🏛 American Society for Investigative Pathology 🌐 English ⚖ 770 KB

Increase of C1q biosynthesis in brain mi

Increase of C1q biosynthesis in brain microglia and macrophages during lentivirus infection in the rhesus macaque is sensitive to antiretroviral treatment with 6-chloro-2′,3′-dideoxyguanosine

✍ Candan Depboylu; Martin K.-H. Schäfer; Wilhelm J. Schwaeble; Todd A. Reinhart; H 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 716 KB

113 Antiretroviral therapy during primar

113 Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques : B. Rosenwirth1, P. ten Haaft1, W.M.J.M. Bogers1, I.G. Nieuwenhuis1, H. Niphuis1, E.-M. Kuhn1, N. Bischofberger2, J.L. Heeney1, and K. Überla3 1Biomedical Primate Research Center (BPRC), Rijswijk, The Netherlands; 2Gilead Sciences Inc., Foster City, California, U.S.A.; 3Institute of Virology, University of Leipzig, Leipzig, Germany

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 126 KB